Cliftonlarsonallen Wealth Advisors LLC Raises Stake in The Procter & Gamble Company (NYSE:PG)

Cliftonlarsonallen Wealth Advisors LLC boosted its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 44.7% in the third quarter, HoldingsChannel reports. The institutional investor owned 46,233 shares of the company’s stock after purchasing an additional 14,290 shares during the period. Cliftonlarsonallen Wealth Advisors LLC’s holdings in Procter & Gamble were worth $8,008,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Alera Investment Advisors LLC lifted its stake in Procter & Gamble by 1.2% during the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock worth $812,000 after purchasing an additional 60 shares during the last quarter. Hudson Value Partners LLC grew its position in shares of Procter & Gamble by 4.1% in the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after buying an additional 60 shares during the last quarter. Traveka Wealth LLC boosted its stake in Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after acquiring an additional 60 shares in the last quarter. Fiduciary Alliance LLC grew its holdings in shares of Procter & Gamble by 2.8% during the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after purchasing an additional 61 shares during the last quarter. Finally, Allen Mooney & Barnes Investment Advisors LLC lifted its holdings in shares of Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock valued at $1,507,000 after purchasing an additional 61 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

Shares of PG stock opened at $172.64 on Tuesday. The stock has a fifty day moving average price of $171.57 and a 200 day moving average price of $166.88. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The stock has a market cap of $407.45 billion, a PE ratio of 28.21, a P/E/G ratio of 3.67 and a beta of 0.41. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. During the same quarter in the previous year, the company posted $1.37 EPS. The business’s revenue was down .1% on a year-over-year basis. Sell-side analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.33%. Procter & Gamble’s dividend payout ratio is currently 65.69%.

Insiders Place Their Bets

In related news, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the sale, the chief executive officer now owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO R. Alexandra Keith sold 3,373 shares of the company’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the transaction, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now directly owns 269,172 shares in the company, valued at approximately $46,203,373.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 383,194 shares of company stock valued at $65,140,718. Corporate insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the topic of several research analyst reports. Piper Sandler assumed coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and reduced their price objective for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Finally, DA Davidson assumed coverage on shares of Procter & Gamble in a research note on Wednesday, October 9th. They issued a “neutral” rating and a $159.00 price objective on the stock. Nine research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $176.21.

Check Out Our Latest Research Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.